Introduction
Benozol BR is a prescription medicine having a combination of medicines that is used to treat glaucoma. It works by decreasing the pressure of fluid in ... View More
Uses of Benozol BR
Side effects of Benozol BR
How to use Benozol BR
This medicine is for external use only. Take it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the ... View More
How Benozol BR works
Benozol BR is a combination of two medicines: Brinzolamide and Brimonidine. Brinzolamide is a carbonic anhydrase inhibitor while Brimonidine is a sympat... View More
Indication
Open-angle glaucoma, Ocular hypertension
Administration
Shake well before use If more than 1 ophthalmic drop is administered, the drugs should be administered at least 5 minutes apart
Adult Dose
The recommended dose is one drop in the affected eye(s) 2-3 times daily.
Child Dose
<2 years: Safety and efficacy not established >2 years: Instill 1 drop in the affected eye(s) 2-3 times daily.
Contraindication
This eye drops are contraindicated in patients who are hypersensitive to any component of this product.
Mode of Action
Brinzolamide is a carbonic anhydrase inhibitor that decreases secretion of aqueous humor thus reducing intraocular pressure. Brimonidine is an alpha 2-... View More
Precaution
Hepatic and renal impairment; pregnancy. Efficacy has not been established in angle-closure glaucoma. Ensure an interval of at least 10 minutes between ... View More
Side Effect
>10% (brimonidine) Somnolence in children (50-83%),Xerostomia (10-30%),Ocular hyperemia (10-30%),Burning and stinging (10-30%),Headache (10-30%),Blurri... View More
Pregnancy Category Note
Pregnancy Category: C Lactation: Unknown whether distributed in human breast milk; do not breast feed
Interaction
Brinzolamide: Concurrent use w/ oral carbonic anhydrase inhibitors may lead to additive systemic effects. Concurrent use w/ high-dose salicylates may le... View More
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More